Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 4, 2005, Pages 1019-1034

  Peeters, Stephanie T H ^a   Heemsbergen, Wilma D ^a   Van Putten, Wim L J ^b   Slot, Annerie ^c   Tabak, Hans ^d   Mens, Jan Willem ^b   Lebesque, Joos V ^a   Koper, Peter C M ^b  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Radiotherapeutic Institute Friesland   (Netherlands)

^d Zeeuws Radiotherapeutic Institute   (Netherlands)

Author keywords

Dose; Prognostic factors; Prostate cancer; Radiotherapy; Randomized trial; Toxicity

Indexed keywords

CLINICAL TARGET VOLUME (CTV); GASTROINTESTINAL (GI); GENITOURINARY (GU); HORMONAL TREATMENT (HT); RADIATION THERAPY ONCOLOGY GROUP (RTOG); SCORING SYSTEMS;

BLOOD VESSELS; DOSIMETRY; GASTROENTEROLOGY; HORMONES; HOSPITALS; ONCOLOGY; PATIENT TREATMENT; RISK ASSESSMENT; SURGERY; TOXICITY; TUMORS;

RADIOTHERAPY;

ANTIANDROGEN; GONADORELIN; PROSTATE SPECIFIC ANTIGEN; STEROID;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ABDOMINAL SURGERY; ACUTE TOXICITY; ADULT; AGE; AGED; ANAMNESIS; ARTICLE; BLOOD TRANSFUSION; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER RISK; CANCER STAGING; CLINICAL TRIAL; COLITIS; COLON PERFORATION; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAPER; DYSURIA; EVALUATION; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEALTH CARE ORGANIZATION; HORMONAL THERAPY; HOSPITAL; HUMAN; INCIDENCE; INTESTINE SURGERY; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MELENA; MULTICENTER STUDY; NOCTURIA; ONCOLOGY; PREDICTION; PRIORITY JOURNAL; PROCTITIS; PROGNOSIS; PROSTATE ADENOCARCINOMA; RADIATION DOSE FRACTIONATION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECTUM HEMORRHAGE; SCORING SYSTEM; SELF REPORT; SEMINAL VESICLE; SIGMOID; THREE DIMENSIONAL IMAGING; TRANSURETHRAL RESECTION; TREATMENT PLANNING; TUMOR DIFFERENTIATION; URINARY TRACT OBSTRUCTION; UROGENITAL TRACT DISEASE;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; URINATION DISORDERS;

EID: 14844302686     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.07.715     Document Type: Article

References (52)

1. G.E. Hanks, K.L. Martz, J.J. Diamond The effect of dose on local control of prostate cancer Int J Radiat Oncol Biol Phys 15 1988 1299 1305
2. A.L. Zietman, J.J. Coen, K.C. Dallow The treatment of prostate cancer by conventional radiation therapy: An analysis of long-term outcome Int J Radiat Oncol Biol Phys 32 1995 287 292
3. M. Bolla, L. Collette, L. Blank Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomized trial Lancet 360 2002 103 108
4. M.V. Pilepich, K. Winter, M.J. John Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate Int J Radiat Oncol Biol Phys 50 2001 1243 1252
5. K.H. Nguyen, E.M. Horwitz, A.L. Hanlon Does short-term androgen deprivation substitute for radiation dose in the treatment of high-risk prostate cancer? Int J Radiat Oncol Biol Phys 57 2003 377 383
6. 103Pd for low-risk prostate cancer: Preliminary PSA outcomes from a prospective randomized multicenter trial Int J Radiat Oncol Biol Phys 57 2003 1297 1303
7. A. Martinez, J. Gonzalez, W. Spencer Conformal high-dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors J Urol 169 2003 974 980
8. W.U. Shipley, L.J. Verhey, J.E. Munzenrider Advanced prostate cancer: The results of a randomized comparative trial of high-dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone Int J Radiat Oncol Biol Phys 32 1995 3 12
9. L.T. Yonemoto, J.D. Slater, C.J. Rossi Jr Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: Preliminary results of a phase I/II study Int J Radiat Oncol Biol Phys 37 1997 21 29
10. K.J. Russell, R.J. Caplan, G.E. Laramore Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: Results of a randomized prospective trial Int J Radiat Oncol Biol Phys 28 1994 47 54
11. M.J. Zelefsky, S.A. Leibel, P.B. Gaudin Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer Int J Radiat Oncol Biol Phys 41 1998 491 500
12. G.E. Hanks, A.L. Hanlon, T.E. Schultheiss Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization, and future directions Int J Radiat Oncol Biol Phys 41 1998 501 510
13. Z. Symon, K.A. Griffith, P.W. McLaughlin Dose escalation for localized prostate cancer: Substantial benefit observed with 3D conformal therapy Int J Radiat Oncol Biol Phys 57 2003 384 390
14. A. Pollack, G.K. Zagars, G. Starkschall Prostate cancer radiation dose response: Results of the M D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 2002 1097 1105
15. D.A. Kuban, A. Pollack, E. Huang Hazards of dose escalation in prostate cancer radiotherapy Int J Radiat Oncol Biol Phys 57 2003 1260 1268
16. G.E. Hanks, A.L. Hanlon, B. Epstein Dose response in prostate cancer with 8-12 years' follow-up Int J Radiat Oncol Biol Phys 54 2002 427 435
17. J.A. Lyons, P.A. Kupelian, D.S. Mohan Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate Urology 55 2000 85 90
18. M.J. Zelefsky, Z. Fuks, M. Hunt High-dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer J Urol 166 2001 876 881
19. G.D. Steinberg, G.T. Bales, C.B. Brendler An analysis of watchful waiting for clinically localized prostate cancer J Urol 159 1998 1431 1436
20. P. Bey, C. Carrie, V. Beckendorf Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer--preliminary results Int J Radiat Oncol Biol Phys 48 2000 513 517
21. J.M. Michalski, J.A. Purdy, K. Winter Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406 Int J Radiat Oncol Biol Phys 46 2000 391 402
22. S.A. Leibel, M.J. Zelefsky, G.J. Kutcher Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: Interim report of a phase 1 dose-escalation study J Urol 152 1994 1792 1798
23. L.J. Boersma, M. van den Brink, A.M. Bruce Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms Int J Radiat Oncol Biol. Phys 41 1998 83 92
24. V. Beckendorf, S. Guerif, E. Le Prise The French 70 Gy versus 80 Gy dose escalation trial for localized prostate cancer: Feasibility and toxicity Int J Radiat Oncol Biol Phys 57 2003 S152 S153
25. A.W. Partin, J. Yoo, H.B. Carter The use of prostate specific antigen, clinical stage, and Gleason score to predict pathological stage in men with localized prostate cancer J Urol 150 1993 110 114
26. C. Rasch, P. Remeijer, P.C. Koper Comparison of prostate cancer treatment in two institutions: A quality control study Int J Radiat Oncol Biol Phys 45 1999 1055 1062
27. L.J. Bos, E.M. Damen, R.W. de Boer Reduction of rectal dose by integration of the boost in the large-field treatment plan for prostate irradiation Int J Radiat Oncol Biol Phys 52 2002 254 265
28. International Commission on Radiation Units and Measurements (ICRU) Report No. 50. Prescribing, recording and reporting photon beam therapy. Bethesda, MD: ICRU; 1993.
29. A. Bel, P.H. Vos, P.T. Rodrigus High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging Int J Radiat Oncol Biol Phys 35 1996 321 332
30. ASTRO Consensus statement: Guidelines for PSA following radiation therapy Int J Radiat Oncol Biol Phys 37 1997 1035 1041
31. D.M. Tait, A.E. Nahum, L.C. Meyer Acute toxicity in pelvic radiotherapy: Randomized trial of conformal versus conventional treatment Radiother Oncol 42 1997 121 136
32. J.D. Cox, J.A. Stetz, T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
33. A.L. Hanlon, T.E. Schultheiss, M.A. Hunt Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales Int J Radiat Oncol Biol Phys 38 1997 59 63
34. G. Goldner, N. Wachter-Gerstner, S. Wachter Acute side effects during 3-D-planned conformal radiotherapy of prostate cancer: Differences between patient's self-reported questionnaire and the corresponding doctor's report Strahlenther Onkol 179 2003 320 327
35. M.R. Storey, A. Pollack, G. Zagars Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial Int J Radiat Oncol Biol Phys 48 2000 635 642
36. A. Zapatero, P. Alcantara, F. Valcarcel Preliminary report of a multicenter Spanish trial (GICOR 05) of risk-adapted androgen ablation combined with dose-escalation 3D conformal therapy for prostate cancer: Impact on early toxicity Int J Radiat Oncol Biol Phys 57 2003 S391 S392
37. R.K. Valicenti, K. Winter, J.D. Cox RTOG 94-06: Is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity? Int J Radiat Oncol Biol Phys 57 2003 614 620
38. J.M. Michalski, J.A. Purdy, K. Winter Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406 Int J Radiat Oncol Biol Phys 46 2000 391 402
39. T.E. Schultheiss, W.R. Lee, M.A. Hunt Late GI and GU complications in the treatment of prostate cancer Int J Radiat Oncol Biol Phys 37 1997 3 11
40. T. Teshima, G.E. Hanks, A.L. Hanlon Rectal bleeding after conformal 3D treatment of prostate cancer: Time to occurrence, response to treatment and duration of morbidity Int J Radiat Oncol Biol Phys 39 1997 77 83
41. B.G. Gardner, A.L. Zietman, W.U. Shipley Late normal tissue sequelae in the second decade after high-dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer J Urol 167 2002 123 126
42. C. Fiorino, G. Sanguineti, C. Cozzarini Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer Int J Radiat Oncol Biol Phys 57 2003 953 962
43. W.G. Smit, P.A. Helle, W.L. van Putten Late radiation damage in prostate cancer patients treated by high-dose external radiotherapy in relation to rectal dose Int J Radiat Oncol Biol Phys 18 1990 23 29
44. M. Liu, T. Pickles, A. Agranovich Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy Int J Radiat Oncol Biol Phys 58 2004 59 67
45. G. Borghede, H. Hedelin Radiotherapy of localized prostate cancer: Analysis of late treatment complications: A prospective study Radiother Oncol 43 1997 139 146
46. G.E. Hanks, T.F. Pajak, A. Porter Phase III trial of long-term adjuvant androgen deprivation after neo-adjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02 J Clin Oncol 21 2003 3972 3978
47. G. Sanguineti, S. Agostinelli, F. Foppiano Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma Br J Cancer 86 2002 1843 1847
48. A. Wells, J.C. Souto, J. Solava Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling Clin Cancer Res 8 2002 1251 1257
49. M.J. Zelefsky, A. Harrison Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: Reducing the potential morbidity of therapy Urology 49 1997 38 45
50. W. Lilleby, S.D. Fossa, B.H. Knutsen Computed tomography/magnetic resonance based volume changes of the primary tumor in patients with prostate cancer with or without androgen deprivation Radiother Oncol 57 2000 195 200
51. A.S. Sandhu, M.J. Zelefsky, H.J. Lee Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection Int J Radiat Oncol Biol Phys 48 2000 643 647
52. D.M. Herold, A.L. Hanlon, G.E. Hanks Diabetes mellitus: A predictor for late radiation morbidity Int J Radiat Oncol Biol Phys 43 1999 475 479